[Drug-induced QT interval prolongation: do we know the risks?]

Med Clin (Barc). 2015 Mar 15;144(6):269-74. doi: 10.1016/j.medcli.2014.01.027. Epub 2014 Mar 18.
[Article in Spanish]

Abstract

Sudden cardiac death is an important cause of mortality in developed countries, most of them being consequence of acute ventricular arrhythmias. These arrhythmias, in some cases, owe to QT interval prolongation. A major risk factor for this condition is the use of drugs that prolong the QT interval. In fact, in recent years, one of the most common reasons for drug withdrawal or usage restrictions has been drug induced QT interval prolongation that involves both cardiovascular and non-cardiovascular drugs. Taking into account the severity that the occurrence of such an event may have, it is important for clinicians to know the risks of these drugs in certain patients. In this review we analyze the drugs that prolong the QT interval, the risk factors that can enhance QT prolongation and the drug interactions that can increase these risks.

Keywords: Drug interactions; Drugs; Factores de riesgo; Fármacos; Interacciones farmacológicas; Prolongación del intervalo QT; QT interval prolongation; Risk factors; Torsade de pointes.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Death, Sudden, Cardiac / etiology
  • Drug Interactions
  • Humans
  • Long QT Syndrome / chemically induced*
  • Long QT Syndrome / complications
  • Long QT Syndrome / prevention & control
  • Risk Factors